June 2026
The global pancreatic cancer precision medicine market size is estimated to hit around USD 4,611.83 million 2035 increasing from USD 823.30 million in 2025, with a CAGR of 18.80%.
September 2026
The global precision medicine market size is expected to increase from USD 138.67 billion in 2026 and is expected to hit around USD 537.17 billion by 2035, with a CAGR of 16.26%.
May 2026
The pancreatic cancer market size was estimated at USD 3.25 billion in 2025 and it is expected to be hit around USD 11.47 billion by 2035 at a CAGR of 13.44%.
February 2026
The artificial intelligence (AI) in precision medicine market size is projected to hit around USD 60.24 billion by 2035 from USD 3.15 billion in 2025 with a CAGR of 34.33%.
December 2025
The global non-oncology precision medicine market size is calculated at USD 92.21 billion in 2025 and is projected to hit around USD 222.95 billion by 2035 with a CAGR of 9.23%.
June 2025
The U.S. precision medicine market size surpassed USD 49.79 billion in 2024 and is predicted to reach around USD 232.49 billion by 2034 with a solid CAGR of 16.66%.
August 2025
The global generative AI in personalized medicine market size reached USD 1.84 billion in 2024 and is projected to hit around USD 57.33 billion by 2034 with a CAGR of 38.24%
September 2025
The global metabolomics market size was evaluated at USD 3.77 billion in 2024 and is predicted to hit around USD 14.40 billion by 2034, growing at a CAGR of 14.34%.
August 2025
The next-generation RNA therapeutics market is growing with innovations in RNA-based drugs, improving treatments for cancer, genetic diseases, and infectious conditions.
July 2025
The global artificial intelligence in bioinformatics market size was evaluated at USD 8.80 billion in 2024 and is predicted to hit around USD 33.52 billion by 2034, at a CAGR of 14.31%.
September 2026
The global telemedicine market size is anticipated at USD 188.93 billion in 2026 and is hit around USD 806.89 billion by 2035, expanding at a CAGR of 17.55%.
September 2026
The global non-invasive cancer diagnostics market size is projected to hit around USD 350.78 billion by 2035 from USD 185.94 billion in 2026, with a CAGR of 7.32%.
September 2026
The cancer immunotherapy market size is calculated at USD 151.26 billion in 2026 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
September 2026
The breast cancer diagnostics market size is valued at USD 21.78 billion in 2026 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
September 2026
The global complementary and alternative medicine market size is valued at USD 241.70 billion in 2026 and is expected to hit around USD 1,412.89 billion by 2035 with a CAGR of 22.00%.
September 2026
The global precision aquaculture market size is projected to hit around USD 1,020.35 million by 2034 from USD 616.53 million in 2026 with a CAGR of 6.50%.
September 2026
The global nuclear medicine equipment market size is estimated to hit around USD 10.00 billion by 2035 increasing from USD 7.57 billion in 2026, with a CAGR of 3.14%.
September 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 2.14 billion in 2026 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
September 2026
The U.S. concierge medicine market generated USD 6.99 billion in 2026, with prominent U.S. concierge medicine market companies including Priority Physicians, Inc., Castle Connolly Private Health Partners, PartnerMD, Concierge Consultants and CardiologyÂ
September 2026
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
September 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 12.46 billion in 2026, with a CAGR of 6.83%.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The global prostate cancer diagnostics market size is expected to hit around USD 18 billion by 2035 from USD 10.34 billion in 2026 , with a CAGR of 6.36%.
September 2026
The global precision turned product manufacturing market size is estimated to hit around USD 196.11 billion by 2034 increasing from USD 122.39 billion in 2026, with a CAGR of 6.07%.
September 2026
The global cancer diagnostics market size was exhibited at USD 184.96 billion in 2026 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
September 2026
The regenerative medicine market size is valued at USD 53.65 billion in 2026 and is expected to hit around USD 234.85 billion by 2035, growing at a CAGR of 18.29%.
September 2026
The in-vitro colorectal cancer screening tests market size is projected to surge around USD 1,310 million by 2034 from USD 1030 million in 2026, with a CAGR of 3.05%.
September 2026
The global breast cancer market size was estimated at USD 27.37 billion in 2026 and is projected to hit around USD 40.11 billion by 2035 with a CAGR of 4.34%.
September 2026
The global Cancer IVD market size was estimated at USD 21.87 billion in 2026 and is projected to hit around USD 34.97 billion by 2034 with a notable CAGR of 6.04%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com